Benzonatate
- Product NDC
- 70934-925
- 11-digit product format
- 709340925
- Labeler code
- 70934
- Product ID
- 70934-925_f15ec9ef-1d4c-4a8b-e053-2a95a90a43e5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA091133
- Marketing category
- ANDA
- Marketing start
- 2021-12-27
- Marketing end
- 2023-03-31
- Substance
- BENZONATATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70934-925-20 | 70934092520 | 20 CAPSULE in 1 BOTTLE, PLASTIC (70934-925-20) | 20 capsule | 2021-12-28 | 0000-00-00 | No | No | Current |
| 70934-925-30 | 70934092530 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-925-30) | 30 capsule | 2021-12-27 | 0000-00-00 | No | No | Current |